Washington [US], November 16 (ANI): A new study of health records from 87 health care centres across the United States found that people taking a class of antidepressants called selective serotonin reuptake inhibitors (SSRIs) were less likely to die of COVID-19.
London [UK], October 22 (ANI): A drug used to treat agitation in people with dementia is no more effective than a placebo, and might even increase mortality, according to a new study.
Amsterdam [Netherlands], October 9 (ANI): The findings of a pilot study has found that depressed patients, who suffered from COVID respond better to standard antidepressants than people who haven't had COVID.
Amsterdam [Netherlands], October 5 (ANI): A pilot study has shown that depressed patients who have suffered from COVID respond better to standard antidepressants than people who have not had COVID.
London [UK], September 30 (ANI): The findings of a new study led by UCL researchers suggests that when people stop taking antidepressants after a long period of use, just over half (56 per cent) experience a relapse within a year, compared to 39 per cent of those who stay on medication.
Washington [US], July 15 (ANI): The findings of a new study suggest that people with diabetes and depression who take antidepressants might face a lower risk of serious diabetes complications and death.
New Delhi [India], June 20 (ANI): Mental health experts have observed an overall 20 per cent rise in anti-depressant intake among people since the second COVID-19 wave devastated the country.
Southampton [UK], April 23 (ANI): The findings of a new study suggest that while much is known about the ever-increasing uptake of antidepressant medications around the world, there is very little evidence on safe and effective approaches to discontinuing treatment.
California [US], February 1 (ANI): A team of researchers has found that an enriched diet and companionship can reduce pain in mice with sickle cell disease by increasing serotonin. They also discovered that duloxetine, an antidepressant that boosts serotonin levels, could be an alternative t
Canberra [Australia], January 23 (ANI): Stimulant medications are generally inadequate for back and osteoarthritis pain, in spite of being broadly utilized for these conditions, suggests a study published by the British Medical Journal (BMJ).
Canberra [Australia], January 21 (ANI): A study published by the British Medical Journal (BMJ) provides evidence that stimulant medications are generally inadequate for back and osteoarthritis pain, in spite of being broadly utilized for these conditions.